Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 124 citing articles:

COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 179
Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial
Meera Madhavan, Adam Ritchie, Jeremy Aboagye, et al.
EBioMedicine (2022) Vol. 85, pp. 104298-104298
Open Access | Times Cited: 114
Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
Shen Wang, Bo Liang, Weiqi Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 97
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report
Jane M. Knisely, Lucas E. Buyon, Rebecca Mandt, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 73
Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization
Tong Ye, Zhouguang Jiao, Xin Li, et al.
Nature (2023) Vol. 624, Iss. 7992, pp. 630-638
Closed Access | Times Cited: 67
Mucosal vaccines for SARS-CoV-2: triumph of hope over experience
Devaki Pilapitiya, Adam K. Wheatley, Hyon‐Xhi Tan
EBioMedicine (2023) Vol. 92, pp. 104585-104585
Open Access | Times Cited: 50
Pulmonary inhalation for disease treatment: Basic research and clinical translations
Bin Wang, Lin Wang, Qian Yang, et al.
Materials Today Bio (2024) Vol. 25, pp. 100966-100966
Open Access | Times Cited: 26
Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications
Ming Zhou, Haihua Xiao, Xinyi Yang, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access | Times Cited: 3
Challenges and developments in universal vaccine design against SARS-CoV-2 variants
Fangxin Zhao, Xiaodong Zai, Zhiling Zhang, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 60
Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin®)
Chandramani Singh, Savita Verma, Prabhakar Reddy, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 42
Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial
Rong Tang, Hui Zheng, Busen Wang, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 7, pp. 613-623
Open Access | Times Cited: 36
Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial
Jingxin Li, Lihua Hou, Jin-Bo Gou, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 10, pp. 1143-1152
Open Access | Times Cited: 34
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control
Shen Wang, Wujian Li, Zhenshan Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 10
Molecular basis of Ad5-nCoV vaccine-induced immunogenicity
Dongyang Dong, Yutong Song, Shipo Wu, et al.
Structure (2025)
Open Access | Times Cited: 1
Comparison of the Effectiveness and Safety of Heterologous Booster Doses with Homologous Booster Doses for SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis
Jie Deng, Yirui Ma, Qiao Liu, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 17, pp. 10752-10752
Open Access | Times Cited: 36
Modelling the adjustment of COVID-19 response and exit from dynamic zero-COVID in China
Kathy Leung, GM Leung, Joseph T. Wu
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 31
Immunization with matrix-, nucleoprotein and neuraminidase protects against H3N2 influenza challenge in pH1N1 pre-exposed pigs
Eleni Vatzia, Katherine Feest, Adam McNee, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 19
Promises and challenges of mucosal COVID-19 vaccines
Abhay P. S. Rathore, Ashley L. St. John
Vaccine (2023) Vol. 41, Iss. 27, pp. 4042-4049
Open Access | Times Cited: 18
Long-term effects of Omicron BA.2 breakthrough infection on immunity-metabolism balance: a 6-month prospective study
Yanhua Li, Shijie Qin, Lei Dong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1
Xian Li, Mengxin Xu, Jingyi Yang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice
Stefan Slamanig, Irene González‐Domínguez, Lauren A Chang, et al.
EBioMedicine (2024) Vol. 105, pp. 105185-105185
Open Access | Times Cited: 8
Recent Developments in Aerosol Pulmonary Drug Delivery: New Technologies, New Cargos, and New Targets
Ian R. Woodward, Catherine A. Fromen
Annual Review of Biomedical Engineering (2024) Vol. 26, Iss. 1, pp. 307-330
Closed Access | Times Cited: 7
Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants
Jiaying Zhong, Shuo Liu, Tingting Cui, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2689-2697
Open Access | Times Cited: 28
Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial
Lairun Jin, Rong Tang, Shipo Wu, et al.
Emerging Microbes & Infections (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections
Ching-Yee Loo, Wing‐Hin Lee, Qi Zhou
Pharmaceutical Research (2023) Vol. 40, Iss. 5, pp. 1015-1036
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top